Clinical Trials Browser

Unknown × Has results × pemigatinib × Clear all

NCT04096417 2024-02-21

Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations

Phase 2 Unknown

14 enrolled 11 charts

Gastrointestinal

Colorectal Neoplasms